Valuation: Elekta AB (publ)

Market Cap 19.64B 2.04B 1.78B 1.64B 1.52B 2.88B 194B 2.93B 7.7B 95.52B 7.64B 7.47B 331B P/E 2027 *
13.6x
P/E 2028 * 12.1x
Enterprise Value 23.12B 2.4B 2.1B 1.94B 1.79B 3.39B 229B 3.44B 9.06B 112B 9B 8.8B 390B EV / Sales 2027 *
1.33x
EV / Sales 2028 * 1.25x
Free-Float
94.03%
Yield 2027 *
4.92%
Yield 2028 * 5.43%

Last Transcript: Elekta AB (publ)

Manager TitleAgeSince
Chief Executive Officer - 2025-08-31
Director of Finance/CFO - 2026-02-28
Investor Relations Contact - 2023-11-30
Director TitleAgeSince
Director/Board Member 69 2010-06-29
Director/Board Member 70 2011-09-14
Chairman 74 2013-09-02
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 2.01B
+0.45%+0.69%+22.36%+1.97% 195B
-1.16%-4.51%-22.67%+19.55% 146B
-0.49%-0.82%-56.89%-15.05% 66.87B
+0.96%-2.29%+17.02%+0.62% 52.59B
+0.61%-1.06%-27.03%-30.23% 43.85B
+0.52%+2.75%+8.15%+13.46% 37.73B
-0.19%-0.75%+6.55%+42.23% 37.03B
-2.20%-2.75%-21.00%-5.88% 30.07B
0.00%-1.32%-15.42%-19.79% 29.43B
Average +0.09%-1.89%-9.88%+0.76% 70.92B
Weighted average by Cap. +0.16%-1.81%-5.60%+3.52%

Financials

2027 *2028 *
Net sales 17.35B 1.8B 1.57B 1.45B 1.34B 2.54B 171B 2.58B 6.8B 84.37B 6.75B 6.6B 293B 18.1B 1.88B 1.64B 1.52B 1.4B 2.65B 179B 2.7B 7.1B 88.05B 7.04B 6.89B 306B
Net income 1.43B 148M 129M 119M 110M 209M 14.09B 212M 559M 6.94B 555M 543M 24.07B 1.61B 166M 146M 134M 124M 235M 15.87B 239M 629M 7.81B 625M 611M 27.1B
Net Debt 3.48B 361M 316M 292M 269M 511M 34.43B 519M 1.37B 16.94B 1.36B 1.33B 58.79B 3B 311M 273M 251M 232M 441M 29.7B 448M 1.18B 14.62B 1.17B 1.14B 50.72B
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-